Report cover image

Digital Therapeutics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published May 01, 2024
Length 130 Pages
SKU # FOB18819948

Description

Digital Therapeutics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Digital Therapeutics Market

The digital therapeutics market size was valued at USD 6.77 billion in 2023, and the market is now projected to grow from USD 8.28 billion in 2024 to USD 43.88 billion by 2032, exhibiting a CAGR of 23.2% during the forecast period of 2024-2032.

A COVID-19 pandemic was a significant issue on a digital therapeutics market growth as the spread of the coronavirus infection was considered an emergency. The impact of COVID-19 on the development of the global DTx market industry can be fantastic in the forecast period. Consequently, the future forecasting requirement and the opportunity to cure at home significantly increased due to quarantine-related COVID-19 pandemic outbreak constraints in the sector.

The global digital therapeutics market share has been increased through the market share contributed due to the increasing cases of chronic disease. Electronic therapeutics market: a number of factors such as the increased pace of the demand for the management and cure of chronic conditions globally pushes the use of therapeutic software and devices.

Additionally, there is a clear history of innovation of these products, with more incorporation of technology. They are helping the healthcare specialists to record and scan medical information frequently and provide more effective treatments for their patients. The outstanding-general performance potentials within the merchandise are a superb aid towards the healthcare industry.

Comprehensive Analysis of Digital Therapeutics Market

The digital therapeutics market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by types of type, application, treatment, and sales channel. The sales channel types include, B2B, and B2C. However, the application is such as prevention and treatment.

The North American region is conducive to the global digital therapeutics market, leading to a recall of USD 3.21 billion owing to growing number of cases of patients suffering from chronic diseases. Moreover, more and more collaborations and agreements among the key gamers to be conscious of the research and improvement of these gadgets are predicted to grow with the advent of these gadgets within the region.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Omada Health Inc. (U.S.), JOGOHEALTH (U.S.), Fitbit Health Solutions (U.S.), Welldoc, Inc. (U.S.), CANARY HEALTH (U.S.), CureApp, Inc. (Japan), Propeller Health (U.S.), Brain+ A/S (Denmark), GAIA AG (Germany), and Pear Therapeutics, Inc. (U.S.) these market players provide a level-playing competitive landscape.

In January 2023, Lupin, a wholly-owned subsidiary of Lupin Limited, announced the release of its therapeutic solution, LYFE. LYFE is India’s handiest proof-based holistic heart care program that considerably reduces the danger of a coronary heart attack and improves vitals and quality of life for cardiac patients.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 23.2% from 2024-2032

Unit Value (USD billion)

Segmentation By Type

Devices

Software & Services

By Application

Preventive

Prediabetes

Obesity

Others

Treatment

Diabetes

Respiratory Care

Mental Health

Cardiovascular

Others

By Sales Channel

B2B

B2C

By Region

North America (By Type, By Application, By Sales Channel, By Country)

U.S.

Canada

Europe (By Type, By Application, By Sales Channel, By Country/sub-region)

U.K.

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific (By Type, By Application, By Sales Channel, By Country/sub-region)

Japan

China

India

Australia

Rest of Asia Pacific

Rest of the World ( By Type, By Application, By Sales Channel )


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

130 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Emerging Trends
4. Key Insights
4.1. Overview of the Parent/Related Markets
4.2. Industry SWOT Analysis
4.3. Supply Chain and Regulatory Analysis
4.4. Recent Industry Developments - Policies, Partnerships, New Product Launches, and Mergers & Acquisitions
4.5. Qualitative Analysis (in relation to COVID-19)
4.5.1. Impact of COVID-19
4.5.2. Supply Chain Challenges
4.5.3. Potential Opportunities due to COVID-19
5. Global Shampoo Market Analysis, Insights, and Forecast, 2019-2032
5.1. Key Findings / Summary
5.2. Market Size Estimates and Forecast
5.2.1. By Product Type (Value)
5.2.1.1. Medicated/Special-Purpose
5.2.1.2. Non-Medicated/Regular
5.2.2. By Form (Value)
5.2.2.1. Liquid
5.2.2.2. Solid
5.2.2.3. Others
5.2.3. By Application (Value)
5.2.3.1. Household
5.2.3.2. Commercial
5.2.4. By Distribution Channel (Value)
5.2.4.1. Hypermarkets/Supermarkets
5.2.4.2. Convenience Stores
5.2.4.3. Online Stores
5.2.4.4. Others
5.2.5. By Region (Value)
5.2.5.1. North America
5.2.5.2. Europe
5.2.5.3. Asia Pacific
5.2.5.4. South America
5.2.5.5. Middle East & Africa
6. North America Shampoo Market Analysis, Insights and Forecast, 2019-2032
6.1. Key Findings / Summary
6.2. Market Size Estimates and Forecast
6.2.1. By Product Type (Value)
6.2.1.1. Medicated/Special-Purpose
6.2.1.2. Non-Medicated/Regular
6.2.2. By Form (Value)
6.2.2.1. Liquid
6.2.2.2. Solid
6.2.2.3. Others
6.2.3. By Application (Value)
6.2.3.1. Household
6.2.3.2. Commercial
6.2.4. By Distribution Channel (Value)
6.2.4.1. Hypermarkets/Supermarkets
6.2.4.2. Convenience Stores
6.2.4.3. Online Stores
6.2.4.4. Others
6.2.5. By Country (Value)
6.2.5.1. U.S
6.2.5.1.1. By Product Type (Value)
6.2.5.1.1.1. Medicated/Special-Purpose
6.2.5.1.1.2. Non-Medicated/Regular
6.2.5.2. Canada
6.2.5.2.1. By Product Type (Value)
6.2.5.2.1.1. Medicated/Special-Purpose
6.2.5.2.1.2. Non-Medicated/Regular
6.2.5.3. Mexico
6.2.5.3.1. By Product Type (Value)
6.2.5.3.1.1. Medicated/Special-Purpose
6.2.5.3.1.2. Non-Medicated/Regular
7. Europe Shampoo Market Analysis, Insights and Forecast, 2019-2032
7.1. Key Findings / Summary
7.2. Market Size Estimates and Forecast
7.2.1. By Product Type (Value)
7.2.1.1. Medicated/Special-Purpose
7.2.1.2. Non-Medicated/Regular
7.2.2. By Form (Value)
7.2.2.1. Liquid
7.2.2.2. Solid
7.2.2.3. Others
7.2.3. By Application (Value)
7.2.3.1. Household
7.2.3.2. Commercial
7.2.4. By Distribution Channel (Value)
7.2.4.1. Hypermarkets/Supermarkets
7.2.4.2. Convenience Stores
7.2.4.3. Online Stores
7.2.4.4. Others
7.2.5. By Country (Value)
7.2.5.1. U.K.
7.2.5.1.1. By Product Type (Value)
7.2.5.1.1.1. Medicated/Special-Purpose
7.2.5.1.1.2. Non-Medicated/Regular
7.2.5.2. Germany
7.2.5.2.1. By Product Type (Value)
7.2.5.2.1.1. Medicated/Special-Purpose
7.2.5.2.1.2. Non-Medicated/Regular
7.2.5.3. France
7.2.5.3.1. By Product Type (Value)
7.2.5.3.1.1. Medicated/Special-Purpose
7.2.5.3.1.2. Non-Medicated/Regular
7.2.5.4. Italy
7.2.5.4.1. By Product Type (Value)
7.2.5.4.1.1. Medicated/Special-Purpose
7.2.5.4.1.2. Non-Medicated/Regular
7.2.5.5. Spain
7.2.5.5.1. By Product Type (Value)
7.2.5.5.1.1. Medicated/Special-Purpose
7.2.5.5.1.2. Non-Medicated/Regular
7.2.5.6. Rest of Europe
7.2.5.6.1. By Product Type (Value)
7.2.5.6.1.1. Medicated/Special-Purpose
7.2.5.6.1.2. Non-Medicated/Regular
8. Asia-Pacific Shampoo Market Analysis, Insights and Forecast, 2019-2032
8.1. Key Findings / Summary
8.2. Market Size Estimates and Forecast
8.2.1. By Product Type (Value)
8.2.1.1. Medicated/Special-Purpose
8.2.1.2. Non-Medicated/Regular
8.2.2. By Form (Value)
8.2.2.1. Liquid
8.2.2.2. Solid
8.2.2.3. Others
8.2.3. By Application (Value)
8.2.3.1. Household
8.2.3.2. Commercial
8.2.4. By Distribution Channel (Value)
8.2.4.1. Hypermarkets/Supermarkets
8.2.4.2. Convenience Stores
8.2.4.3. Online Stores
8.2.4.4. Others
8.2.5. By Country (Value)
8.2.5.1. China
8.2.5.1.1. By Product Type (Value)
8.2.5.1.1.1. Medicated/Special-Purpose
8.2.5.1.1.2. Non-Medicated/Regular
8.2.5.2. India
8.2.5.2.1. By Product Type (Value)
8.2.5.2.1.1. Medicated/Special-Purpose
8.2.5.2.1.2. Non-Medicated/Regular
8.2.5.3. Japan
8.2.5.3.1. By Product Type (Value)
8.2.5.3.1.1. Medicated/Special-Purpose
8.2.5.3.1.2. Non-Medicated/Regular
8.2.5.4. South Korea
8.2.5.4.1. By Product Type (Value)
8.2.5.4.1.1. Medicated/Special-Purpose
8.2.5.4.1.2. Non-Medicated/Regular
8.2.5.5. Australia
8.2.5.5.1. By Product Type (Value)
8.2.5.5.1.1. Medicated/Special-Purpose
8.2.5.5.1.2. Non-Medicated/Regular
8.2.5.6. Rest of Asia-Pacific
8.2.5.6.1. By Product Type (Value)
8.2.5.6.1.1. Medicated/Special-Purpose
8.2.5.6.1.2. Non-Medicated/Regular
9. South America Shampoo Market Analysis, Insights and Forecast, 2019-2032
9.1. Key Findings / Summary
9.2. Market Size Estimates and Forecast
9.2.1. By Product Type (Value)
9.2.1.1. Medicated/Special-Purpose
9.2.1.2. Non-Medicated/Regular
9.2.2. By Form (Value)
9.2.2.1. Liquid
9.2.2.2. Solid
9.2.2.3. Others
9.2.3. By Application (Value)
9.2.3.1. Household
9.2.3.2. Commercial
9.2.4. By Distribution Channel (Value)
9.2.4.1. Hypermarkets/Supermarkets
9.2.4.2. Convenience Stores
9.2.4.3. Online Stores
9.2.4.4. Others
9.2.5. By Country (Value)
9.2.5.1. Brazil
9.2.5.1.1. By Product Type (Value)
9.2.5.1.1.1. Medicated/Special-Purpose
9.2.5.1.1.2. Non-Medicated/Regular
9.2.5.2. Argentina
9.2.5.2.1. By Product Type (Value)
9.2.5.2.1.1. Medicated/Special-Purpose
9.2.5.2.1.2. Non-Medicated/Regular
9.2.5.3. Rest of South America
9.2.5.3.1. By Product Type (Value)
9.2.5.3.1.1. Medicated/Special-Purpose
9.2.5.3.1.2. Non-Medicated/Regular
10. Middle East & Africa Shampoo Market Analysis, Insights and Forecast, 2019-2032
10.1. Key Findings / Summary
10.2. Market Size Estimates and Forecast
10.2.1. By Product Type (Value)
10.2.1.1. Medicated/Special-Purpose
10.2.1.2. Non-Medicated/Regular
10.2.2. By Form (Value)
10.2.2.1. Liquid
10.2.2.2. Solid
10.2.2.3. Others
10.2.3. By Application (Value)
10.2.3.1. Household
10.2.3.2. Commercial
10.2.4. By Distribution Channel (Value)
10.2.4.1. Hypermarkets/Supermarkets
10.2.4.2. Convenience Stores
10.2.4.3. Online Stores
10.2.4.4. Others
10.2.5. By Country (Value)
10.2.5.1. UAE
10.2.5.1.1. By Product Type (Value)
10.2.5.1.1.1. Medicated/Special-Purpose
10.2.5.1.1.2. Non-Medicated/Regular
10.2.5.2. South Africa
10.2.5.2.1. By Product Type (Value)
10.2.5.2.1.1. Medicated/Special-Purpose
10.2.5.2.1.2. Non-Medicated/Regular
10.2.5.3. Saudi Arabia
10.2.5.3.1. By Product Type (Value)
10.2.5.3.1.1. Medicated/Special-Purpose
10.2.5.3.1.2. Non-Medicated/Regular
10.2.5.4. Rest of Middle East & Africa
10.2.5.4.1. By Product Type (Value)
10.2.5.4.1.1. Medicated/Special-Purpose
10.2.5.4.1.2. Non-Medicated/Regular
11. Competitive Matrix
11.1. Business Strategies Adopted by Leading Players
11.2. Global Shampoo Market Revenue Share/Ranking Analysis, By Key Manufacturer
12. Company Profiles
12.1. L’Oreal S.A.
12.1.1. Overview
12.1.2. Description
12.1.3. Product Portfolio
12.1.4. Financials (Data as available in public domain and/or on paid databases)
12.1.5. Recent Developments
12.2. Unilever
12.2.1. Overview
12.2.2. Description
12.2.3. Product Portfolio
12.2.4. Financials (Data as available in public domain and/or on paid databases)
12.2.5. Recent Developments
12.3. Shiseido Co. Ltd.
12.3.1. Overview
12.3.2. Description
12.3.3. Product Portfolio
12.3.4. Financials (Data as available in public domain and/or on paid databases)
12.3.5. Recent Developments
12.4. Proctor & Gamble Co.
12.4.1. Overview
12.4.2. Description
12.4.3. Product Portfolio
12.4.4. Financials (Data as available in public domain and/or on paid databases)
12.4.5. Recent Developments
12.5. Henkel AG & Co. KGaA
12.5.1. Overview
12.5.2. Description
12.5.3. Product Portfolio
12.5.4. Financials (Data as available in public domain and/or on paid databases)
12.5.5. Recent Developments
12.6. Johnson & Johnson
12.6.1. Overview
12.6.2. Description
12.6.3. Product Portfolio
12.6.4. Financials (Data as available in public domain and/or on paid databases)
12.6.5. Recent Developments
12.7. Coty Inc.
12.7.1. Overview
12.7.2. Description
12.7.3. Product Portfolio
12.7.4. Financials (Data as available in public domain and/or on paid databases)
12.7.5. Recent Developments
12.8. Estee Lauder Co. Inc.
12.8.1. Overview
12.8.2. Description
12.8.3. Product Portfolio
12.8.4. Financials (Data as available in public domain and/or on paid databases)
12.8.5. Recent Developments
12.9. Kao Corporation
12.9.1. Overview
12.9.2. Description
12.9.3. Product Portfolio
12.9.4. Financials (Data as available in public domain and/or on paid databases)
12.9.5. Recent Developments
12.10. Beiersdorf AG
12.10.1. Overview
12.10.2. Description
12.10.3. Product Portfolio
12.10.4. Financials (Data as available in public domain and/or on paid databases)
12.10.5. Recent Developments
13. Appendix

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us